The group weighed considerations about newer variants and raised concerns that a strain recommendation might interface with the FDA's new proposed COVID vaccine framework.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
As labs rush to determine variant prevalence, the CDC warns it could put more pressure on US hospitals.
An Italian study in the Journal of Antimicrobial Chemotherapy yesterday found that 21.9% of hospitalized COVID-19 patients acquired bacterial or fungal superinfections—infection by a secondary pathogen—that complicated the course of their recovery.
On top of general hesitancy, vaccine attitudes reflected concerns about government interference in the process, including with scientific evaluation.
UK vaccine advisors also recommend 12 week intervals between doses of both vaccines to protect more people with initial doses.
The incoming administration's goals are to take stronger federal leadership to get efforts back on track and speed vaccination by five or six times its current pace.
In other developments, Australia and Japan reported cases involving the South African SARS-CoV-2 variant.
Older people, Asians, and those with Medicaid coverage and preference for a non-English language at one US hospital system had fewer completed telemedicine visits than their peers during the COVID-19 pandemic, according to a study of patients scheduled for primary care or specialty telehealth visits at the University of Pennsylvania.
As cases soar in both the UK and South Africa, scientists are scrambling to detail variant virus characteristics.
The next few months could be difficult, if Christmas and New Years gatherings and travel seed a new surge in infections.
A study of hospital air contamination in JAMA Network Open last week found that 17.4% of air samples from environments near COVID-19 patients were positive for SARS-CoV-2 RNA, the virus that causes COVID-19, but only 8.6% contained viable virus.
